IHS Chemical Week

People & Business :: M&A

Reckitt Benckiser continuing to review pharma options

10:51 AM MST | February 12, 2014 | Natasha Alperowicz

Consumer goods group Reckitt Benckiser (Slough, UK) today announced its quarterly and annual results and said that it is still reviewing the future of its pharmaceuticals business. Fourth-quarter sales were 5% higher at constant exchange rates, at £2.5 billion ($4.1 billion). Quarterly profits have not been disclosed. Full-year 2013 net income was down 5%, to £1.74 billion, on 5% higher sales, at £10 billion. “Our strategy for growth and outperformance through driving health and hygiene power brands together with our focus on 16 power...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa